Literature DB >> 35771439

Characterizing the Electron Transport Chain: Functional Approach Using Extracellular Flux Analyzer on Mouse Tissue Samples.

Ting Liang1,2, Jay Dunn3, Xin Zou4, Bijaya Nayak2, Yuji Ikeno5, Lihong Fan6, Yidong Bai7.   

Abstract

The Seahorse Extracellular Flux Analyzer enables the high-throughput characterization of oxidative phosphorylation capacity based on the electron transport chain organization and regulation with relatively small amount of material. This development over the traditional polarographic Clark-type electrode approaches make it possible to analyze the respiratory features of mitochondria isolated from tissue samples of particular animal models. Here we provide a description of an optimized approach to carry out multi-well measurement of O2 consumption, with the Agilent Seahorse XFe96 analyzer on mouse brain and muscles to determine the tissue-specific oxidative phosphorylation properties. Protocols include the preparation of the tissue samples, isolation of mitochondria, and analysis of their function; in particular, the preparation and optimization of the reagents and samples.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain; Electron transport chain; Muscle; O2 consumption; Seahorse

Mesh:

Year:  2022        PMID: 35771439     DOI: 10.1007/978-1-0716-2309-1_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

Review 1.  Mitochondrial genetics and human disease.

Authors:  L I Grossman; E A Shoubridge
Journal:  Bioessays       Date:  1996-12       Impact factor: 4.345

Review 2.  Mouse models for mitochondrial disease.

Authors:  D C Wallace
Journal:  Am J Med Genet       Date:  2001

Review 3.  Respiratory supercomplexes: structure, function and assembly.

Authors:  Rasika Vartak; Christina Ann-Marie Porras; Yidong Bai
Journal:  Protein Cell       Date:  2013-07-05       Impact factor: 14.870

Review 4.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-09       Impact factor: 5.187

Review 5.  Mouse models of mitochondrial disease, oxidative stress, and senescence.

Authors:  S Melov; P E Coskun; D C Wallace
Journal:  Mutat Res       Date:  1999-07-30       Impact factor: 2.433

Review 6.  Mitochondrial respiratory complex I: structure, function and implication in human diseases.

Authors:  Lokendra K Sharma; Jianxin Lu; Yidong Bai
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 7.  Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.

Authors:  Tyler Bahr; Kyle Welburn; Jonathan Donnelly; Yidong Bai
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-24       Impact factor: 6.633

8.  Respiratory chain complex III deficiency due to mutated BCS1L: a novel phenotype with encephalomyopathy, partially phenocopied in a Bcs1l mutant mouse model.

Authors:  Saara Tegelberg; Nikica Tomašić; Jukka Kallijärvi; Janne Purhonen; Eskil Elmér; Eva Lindberg; David Gisselsson Nord; Maria Soller; Nicole Lesko; Anna Wedell; Helene Bruhn; Christoph Freyer; Henrik Stranneheim; Rolf Wibom; Inger Nennesmo; Anna Wredenberg; Erik A Eklund; Vineta Fellman
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

9.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy.

Authors:  Shane E Kruse; William C Watt; David J Marcinek; Raj P Kapur; Kenneth A Schenkman; Richard D Palmiter
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

Review 10.  Human diseases associated with defects in assembly of OXPHOS complexes.

Authors:  Daniele Ghezzi; Massimo Zeviani
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.